Poral, Merry Kenn M.
HRN: 24-69-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2024
MUPIROCIN 2%, 15G (TUBE)
03/20/2024
03/27/2024
TOPICAL
1 Gram
QID
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes